• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Laura Lorenzetti

Stay informed with Laura Lorenzetti’s coverage and analysis.

The New York Times 2015 DealBook Conference
Arts & EntertainmentDon’t Expect Live Sports on Netflix Anytime Soon
By Laura LorenzettiNovember 4, 2015
Masterpieces From The Taubman Collection At Sotheby's
A $500 Million Art Auction Kicks Off Today at Sotheby’s
By Laura LorenzettiNovember 4, 2015
Views of The Facebook Inc. Logo Ahead of Earnings
TechVW’s New Horror And Facebook 3Q–5 Things To Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 4, 2015
King Raises $500 Million in "Candy Crush" Maker's U.S. Offering
TechActivision’s candy crush and Tesla 3Q — 5 things to know today
By Laura Lorenzetti and Geoffrey SmithNovember 3, 2015
Apple Watch fitness milanese loop band
TechIBM’s Watson makes its health care debut on the Apple Watch
By Laura LorenzettiOctober 26, 2015
Why the drug price scandal won’t be enough to keep down prices
RetailWhy the drug price scandal won’t be enough to keep down prices
By Laura LorenzettiOctober 26, 2015
Imprimis Turing Drug
HealthThis company is offering a $1 alternative to Turing’s $750 drug
By Laura LorenzettiOctober 23, 2015
2012 Jackie Robinson Foundation Awards Dinner
FinanceWhy this CEO is missing out on an $80 million payday
By Laura LorenzettiOctober 22, 2015
Former DEA agent gets prison time for stealing bitcoins
TechFormer DEA agent gets prison time for stealing bitcoins
By Laura LorenzettiOctober 22, 2015
Unboxing Apple Inc. iPhone 6s
TechInstagram has an answer to the iPhone’s coolest feature
By Laura LorenzettiOctober 22, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceForget the plunging stock price, here’s Valeant’s biggest problem
By Laura LorenzettiOctober 22, 2015
Kate Moss Modelling Contracts At Risk
RetailHere’s how Burberry is taking to Snapchat again
By Laura LorenzettiOctober 22, 2015
Microsoft finally has a laptop to compete with Apple
TechMicrosoft finally has a laptop to compete with Apple
By Laura LorenzettiOctober 21, 2015
AB InBev And SABMiller Beers On Display Following $106 Billion Deal
RetailDrink Beck’s? You can expect some checks
By Laura LorenzettiOctober 21, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
HealthShort-seller: Is Valeant the pharmaceutical Enron?
By Laura LorenzettiOctober 21, 2015
1...
  • 20
  • 21
  • 22
  • 23
  • 24
...73
Most Popular
Success
'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dreamplaceholder alt text
By Nick LichtenbergJune 16, 2026
Personal Finance
Current price of oil as of June 16, 2026placeholder alt text
By Joseph HostetlerJune 16, 2026
Big Tech
Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AIplaceholder alt text
By Tristan BoveJune 15, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.